Sprout Pharmaceuticals, Inc. — Form D

Sprout Pharmaceuticals, Inc. of RALEIGH, NC, a company, filed a Form D exempt-offering notice with the SEC on 2012-06-29. The offering totals $20.0M, of which $17.6M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
W. Robert DahlDirectorRaleigh, NC
Cynthia WhiteheadDirectorSanta Rosa Beach, FL
Cynthia WhiteheadExecutive OfficerSanta Rosa Beach, FL
Douglas S EckertDirectorRaleigh, NC
Douglas S EckertExecutive OfficerRaleigh, NC
Josephine S TorrenteExecutive OfficerRaleigh, NC
Rich S FrancoExecutive OfficerRaleigh, NC
Braxton Robert GoodrichDirectorRaleigh, NC
Richard Robert DeSchutterDirectorRaleigh, NC
Trygve Robert MikkelsenDirectorRaleigh, NC
Michael Robert FordDirectorRaleigh, NC
Trygve W MikkelsenDirectorRaleigh, NC
Anne S TomalinExecutive OfficerRaleigh, NC
Richard W DeSchutterDirectorRaleigh, NC
Robert W DahlDirectorRaleigh, NC
Douglas W EckertDirectorRaleigh, NC
Douglas W EckertExecutive OfficerRaleigh, NC
James S PrudenExecutive OfficerRaleigh, NC
Cynthia S WhiteheadDirectorRaleigh, NC
Cynthia S WhiteheadExecutive OfficerRaleigh, NC
Matthew S PetzoldExecutive OfficerRaleigh, NC
Anthony S WildDirectorRaleigh, NC
Robert S WhiteheadDirectorRaleigh, NC
Robert S WhiteheadExecutive OfficerRaleigh, NC
Michael W FordDirectorRaleigh, NC

Other filings by this issuer (6)

FiledFormOfferingSold
2015-06-08D$50.0M$50.0M
2014-07-11D$15.0M$4.3M
2013-07-26D/A$10.0M$10.0M
2013-06-25D$10.0M$4.8M
2012-07-11D/A$20.0M$20.0M
2012-03-21D$5.0M$5.0M

More